Uncategorized
STAT+: Early signs of Alzheimer’s often go undetected. These researchers want to change that
Researchers in Massachusetts are experimenting with artificial intelligence to detect signs of Alzheimer’s disease in its earliest stages, when symptoms of the dreaded illness may go unnoticed but newer drugs can modestly slow its progression.
Helping more people get diagnosed earlier could be a significant step forward in the fight against the memory-robbing disease. Currently, 90 percent of people in the earliest phase of Alzheimer’s, called mild cognitive impairment, go undiagnosed in the United States, multiple studies show.
“The biggest opportunity to improve Alzheimer’s care isn’t in a new drug — it’s in noticing the earliest signs sooner,” said Dr. Lidia Moura, director of population health in the neurology department at Mass General Brigham.
Researchers in Massachusetts are experimenting with artificial intelligence to detect signs of Alzheimer’s disease in its earliest stages, when symptoms of the dreaded illness may go unnoticed but newer drugs can modestly slow its progression.
Helping more people get diagnosed earlier could be a significant step forward in the fight against the memory-robbing disease. Currently, 90 percent of people in the earliest phase of Alzheimer’s, called mild cognitive impairment, go undiagnosed in the United States, multiple studies show.
“The biggest opportunity to improve Alzheimer’s care isn’t in a new drug — it’s in noticing the earliest signs sooner,” said Dr. Lidia Moura, director of population health in the neurology department at Mass General Brigham.
Uncategorized
Terns rebuffed a higher bid before selling to Merck

Regulatory filings show that Terns ultimately accepted an offer 15% lower than a previous proposal as four companies vied for rights to the coveted leukemia drug developer.

Regulatory filings show that Terns ultimately accepted an offer 15% lower than a previous proposal as four companies vied for rights to the coveted leukemia drug developer.
Uncategorized
STAT+: States looking to regulate use of chatbots
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
Today, a deep dive into why America’s most powerful health insurer is looking more and more like a technology company.
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
Today, a deep dive into why America’s most powerful health insurer is looking more and more like a technology company.
Uncategorized
ARPA-H selects three teams in $100M effort to repair and regrow ailing joints
Three academic centers believe they may have discovered new ways to heal aging joints. Now the federal government is funding clinical trials to test these experimental regenerative medicines in osteoarthritis.
Teams from Duke University, the …
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Contributors9 years agoThe final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years agoAccording to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years agoThe old and New Edition cast comes together to perform
-
Uncategorized9 years agoPhillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years agoUber and Lyft are finally available in all of New York State
-
Uncategorized9 years agoDisney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoSteph Curry finally got the contract he deserves from the Warriors